01582 738464
Professor Alan Sinclair
Professor Sinclair is an internationally and nationally recognised researcher in the field of diabetes in older people. He is a World Health Organization (WHO)-recognised expert in diabetes and in 2014 was appointed to the WHO and International Association of Gerontology and Geriatrics (IAGG) Expert Group on Frailty reflecting his work in the area of diabetes and frailty. He has received numerous awards in recognition of his work, these include the recent 2013 IAGG Presidential Medal: which is the highest honour the IAGG can bestow upon a doctor – this was for services to diabetes.
Isabelle Bourdel-Marchasson
Professor Isabelle Bourdel-Marchasson is the Chair of SIG diabetes EUGMS, chair of “intergroupe diabéto-gériatrie” SFGG and Head of geriatrics education in Aquitaine "My clinical activities are held in geriatric department of CHU of Bordeaux. Particularly, I am the head of geriatric day hospital and post-emergency units. In different settings of the department I have developed strategies to improve care in older people with diabetes whatever their health status, to prevent functional decline and to preserve quality of life. My research is close to my clinical activity and I am the main investigator for several non-drug randomized trials with nutritional or physical activity interventions. The targets of these different trials were functional outcomes, falls, quality of life, pressure ulcer prevention, behavior trouble prevention, and vital prognosis. Nuclear Magnetic Resonance is on the used tool to perform metabolic in vivo studies with muscle NMR spectroscopy or imaging including patients from the ongoing trials but also with animal studies. In Mid frail consortium I was the coordinator for French recruiting sites and the leader of the working package “substudies”. At the national level I am the head of the French “intergroupe diabétogériatrie” of the French "Geriatrics and Gerontological society (SFGG) since 2004. I chair the SIG Diabetes of the EUGMS since 2017. At this time I am in Aquitaine in charge of the new educational program for geriatrician in France."
Giuseppe Paolisso
Born in Benevento, Italy on February 9, 1957, Professor Giuseppe Paolisso is Chancellor of University of Campania, Luigi Vanvitelli, Italy. Member of National Committee for Food Security-National Health Council for Italian Minister of Health. Past President of Italian Society of Gerontology and Geriatrics and Director of Geriatric Residency Program (2002-2014). Full Professor of Internal Medicine and Director of VI Division of Internal Medicine and Geriatrics at University of Campania, Luigi Vanvitelli,( Italy) has developed considerable expertise in geriatric medicine and diabetes care. Prof. Paolisso has documented experience in organization and management of epidemiological and clinical trial studies. He has focused his research interest on molecular, metabolic and cardiovascular aspects of ageing and longevity also recently including the relationships between cognitive and functioning impairment and glucose control in older type 2 diabetic. Prof. Paolisso has attended the following research Institutions: a) 1983-84 at Lab. Of Physiopatology of Insulin Secretion at University of Louvain (Belgium) (Dir. Prof. J.C.Henquin); b) 1984-85 Dept. of Internal Medicine and Diabetes (Dir. Prof. P.Lefebvre) (University of Liege - Belgium); c)1993-94ath National Institute of Health - Clinical Diabetes and Nutrition Section (Dir. Prof. C.Bogardus) (Phoenix USA). Prof. Paolisso is author of almost 437 manuscript which has been published on the main national and international journals with a total Impact Factor greater than 1900 and an H index of 71 .
Ahmed Abdelhafiz
Dr AH Abdelhafiz is a consultant geriatrician and honorary senior clinical lecturer at The Rotherham General Hospital Foundation trust. He is the chair of the Diabetes Interest Group of the British Geriatrics Society and the lead for the North of England of the Older People Diabetes Network. He had several publications and book chapters in the field of diabetes in old age.
Mikel Izquierdo
Professor Mikel Izquierdo is Head and full Professor of Biomechanics and Exercise Physiology in the Department of Health Sciences of the Public University of Navarra. He also holds and an appointment as a professor of Sport Biomechanics at the Centre of Studies of the Spanish Olympic Committee. Additionally, he was the Head of the Unit of the Research, Studies and Sport Medicine Center of the Government of Navarra from 2005-2010. During that time was involved with several olympic gold medals in Rowing, Handball ad Basque ball. He also was involved with the LIVERPOOL AND BARCELONA FC TEAMs with whom won 2 European Championships, as well as the Spanihs cup and League. Principal investigator and collaborator in several EU- funded projects focused on frailty and exercise: VIVIFRAIL to Promote and recommend changes in lifestyle associated with physical exercise for frail patients at risk of functional decline and MID-FRAIL to test the efficacy of a multimodal intervention in prefrail/frail older patients with type 2 diabetes. Actually is collaborating with WHO in the implementation of an physical exercise program as a global strategy of invervention in frailty and risk of falling prevention. His current research interests include the neuromuscular biomechanics of muscle strength and power with special interest in strength training in both the elite athlete and the aging human. Prof. Mikel Izquierdo has published more than 220 original articles in peer-reviewed journals and have been supervisor of more that 20 PhD students. Publications on PubMed:http://goo.gl/zaiGw8.
Andrej Zeyfang
Andrej Zeyfang is Medical Director of the Department of Internal Medicine and Geriatrics and Palliative Care at medius KLINIKEN OSTFILDERN-RUIT. He studied medicine from 1983 to 1989 at the Università Cattolica del Sacro Cuore, Rome, Italy, and went on to specialise in internal medicine, clinical geriatrics, and diabetology. He held the post of a senior physician in the geriatric center of Stuttgart, Germany in 1997, and later obtained a second degree in basic research on trace elements from the University of Tübingen, Germany. Before taking on his current role, Dr Zeyfang was a senior doctor at the Clinic for Geriatric Rehabilitation in Aalen, Germany, and at the Bethesda Geriatric Hospital, Ulm, Germany and from 2006 to 2017 Head of the Department of Internal Medicine, Geriatrics and Diabetology at the Competence Centre for Geriatric Medicine at the Agaplesion Bethesda Hospital, Stuttgart, Germany. From 2002 to 2015, Dr Zeyfang has been Chairman of the diabetes and geriatrics special interest group of the German Diabetes Society, and since now, he is Head of the diabetes special interest group of the German Society for Gerontology and Geriatrics. He is a member of the EAMA, EUGMS and the Scientific Advisory Board of the German Diabetes Foundation. He is peer reviewer for over twenty international journals. He has also been a researcher at the University of Ulm since 2011, and is the country leader of the MID-FRAIL and the VIVIfrail EU-funded research studies. Dr Zeyfang’s main research interests include diabetes in old age, educational programmes for those persons. Moreover, the antioxidative system, frailty, cognition, and technical devices for diabetes therapy management in ambient assisted living (AAL) and digital solutions for elderly are his main topics. He is the author of educational programmes for geriatric patients with diabetes, books about geriatric medicine for students, the “evidence-based guideline on diabetes in old age”, and he contributed to hundreds of articles and books.
Marta Castro-Rodriguez
Dr Marta Castro works as Consultant in Geriatric Medicine at HCOP (Health Care of Older People), in QMC (Queen's Medical Centre Hospital), Nottingham where she is working on developing a Frailty Unit for elderly people, and she works as Honorary Assistant Professor at University of Nottingham, School of Medicine. Before, Dr Castro received training in Geriatric Medicine at the University Hospital of Getafe (Madrid) and worked there for 16 years, under Prof Rodriguez-Manas leadership. Her research initially focused on the clinical investigation of human vascular (endothelial) ageing and on the underlying vascular damage mechanisms in diabetes, but in the last five years the focus of her research has been on the relationships between diabetes and frailty and its implementation in clinical practice. She is a member of the management committee of the Spanish Scientific Society of Geriatric Medicine, the European Union Geriatric Medicine Society (EUGMS) and the American Academy of Geriatric Medicine (ALMA). She has authored original articles, resulting from her collaboration in several European research projects, and book chapters.
Leocadio Rodriguez-Mañas
Head of the Department of Geriatrics at Hospital Universitario de Getafe (Madrid), Professor of Geriatrics at the Universidad Europea de Madrid, Scientific Director of the Spanish Center for Biomedical Research on Frailty and Healthy Aging (CIBERFES) (Ministry of Economy and Competitiveness), and Co-director of the Toledo Study on Healthy Ageing, carried out on 2.895 community-dwelling older people. Principal Investigator in more than 40 externally, peer-reviewed funded projects research including several EU-funded projects focused on frailty. In addition, he is participating in other 5 EU-funded projects. Prof Rodriguez Mañas coordinates since 1st January 2017, on behalf of the Spanish government, the Joint Action ADVANTAGE, funded by DGSANTE, with the aim of building a European roadmap to face in a coordinated and homogeneous way the clinical, organisational and public health challenge of frailty. Prof. Rodriguez-Mañas has published more than 200 original manuscripts in peer reviewed journals, books and book chapters on several aspects of ageing, frailty and diabetes in older people and has participated in performing Technical Reports on those issues for both national (Ministry of Health, Scientific Societies, Research Bodies and Agencies) and international (WHO, PAHO, DG-SANCO, DG-Research, IAGG, etc) organisms.